Genetic Interleukin-6 Receptor Variant Is Not Associated With Rejection and Mortality After Heart Transplantation

Affiliations

• ¹ Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: kaushik.amancherla@vumc.org.
• ² Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
• ³ Department of Medicine, Queen's University, Kingston, Ontario, Canada.
• ⁴ Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee.
• ⁵ Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
• ⁶ Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
• ⁷ Division of Cardiology, Columbia University Medical Center, New York, New York.
• ⁸ Section of Cardio-Oncology and Immunology (JM), University of California San Francisco, San Francisco, California.
• ⁹ Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.